SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)

Quipt Home Medical Corp.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

74880P104

(CUSIP Number)

Robert MacArthur
c/o Forager Fund, L.P.,, 2025 3rd Avenue North, Suite 350
Birmingham, AL, 3520
205-383-4763

Heidi Steele
McDermott Will & Schulte LLP,, 444 West Lake St, Suite 4000
Chicago, IL, 60606
312-984-3624

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

03/16/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP Number(s):

74880P104

Name of reporting person

Forager Fund, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

0.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

74880P104

Name of reporting person

Forager Capital Management, LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

0.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

74880P104

Name of reporting person

Kissel Edward Urban

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

0.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0 %

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

CUSIP Number(s):

74880P104

Name of reporting person

MacArthur Robert Symmes

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

Aggregate amount beneficially owned by each reporting person

0.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0 %

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Shares

(b)

Name of Issuer:

Quipt Home Medical Corp.

(c)

Address of Issuer's Principal Executive Offices:

1019 TOWN DRIVE,, WILDER, KENTUCKY , 41076.

Item 1 Comment:

This Amendment No. 6 ("Amendment No. 6") amends the statement on Schedule 13D filed with the SEC on December 16, 2025 (as amended from time to time, the "Schedule 13D") with respect to the shares of the Issuer. This Amendment No. 6 to Schedule 13D amends Items 4 and 5 as set forth below. Capitalized terms used herein and not otherwise defined have the meanings set forth in the Schedule 13D/A.

Item 2.

Identity and Background

Item 3.

Source and Amount of Funds or Other Consideration

Item 4.

Purpose of Transaction

Item 4 is hereby amended and supplemented as follows: On March 16, 2026, pursuant to the Arrangement Agreement and Plan of Arrangement, the previously announced Arrangement among the Issuer, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware company (individually, "REM Aggregator," and collectively with B.C. Purchaser, "Purchaser" or "Purchasers") was completed, upon which all issued and outstanding common shares of the Issuer were acquired by Purchasers for cash consideration of $3.65 per share, without interest.

Item 5.

Interest in Securities of the Issuer

(a)

Item 5(a) is hereby amended and restated in its entirety as follows: As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares.

(b)

Item 5(b) is hereby amended and restated in its entirety as follows: As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares.

(c)

Item 5(c) is hereby amended and restated in its entirety as follows: Except as described herein with respect to the closing of the Arrangement, the Reporting Persons have not effected any transactions in the common shares of the Issuer during the past sixty days.

(e)

Item 5(e) is hereby amended and restated in its entirety as follows: March 16, 2026

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

Item 7.

Material to be Filed as Exhibits.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Forager Fund, L.P.

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur, Managing Partner
Date:	03/16/2026

Forager Capital Management, LLC

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur, Managing Partner
Date:	03/16/2026

Kissel Edward Urban

Signature:	/s/ Edward Kissel
Name/Title:	Edward Kissel
Date:	03/16/2026

MacArthur Robert Symmes

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur
Date:	03/16/2026

Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.